EP4225755

Aðferð til að handhverfa og einangra atrópísómerur af 7-klór-6-flúor-1-(2-ísóprópýl-4-metýlpýridín-3-ýl)pýridó[2,3-d]pýrimídín-2,4(1H,3H)-díón

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    6.10.2021
  • EP published:
    28.1.2026
  • EP application number:
    21802088.1
  • Max expiry date:
    5.10.2041
  • Expiry date:
    5.10.2026
  • Title in English:
    PROCESS FOR RACEMIZING AND ISOLATING ATROPISOMERS OF 7-CHLORO-6-FLUORO-1-(2-ISOPROPYL-4-METHYLPYRIDIN-3-YL)PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE
  • Language of the patent:
    English

Timeline

Today
6.10.2021EP application
28.1.2026EP Publication
27.3.2026Translation submitted
8.4.2026Registration published
5.10.2026Expires

Owner

  • Name:
    Amgen Inc.
  • Address:
    1 Amgen Center Drive, Thousand Oaks, California 91320-1799, US

Inventor

  • Name:
    BEAVER, Matthew G.
  • Address:
    Thousand Oaks, CA 91320-1799, US
  • Name:
    CORBETT, Michael T.
  • Address:
    Thousand Oaks, CA 91320-1799, US
  • Name:
    FANG, Yuanqing
  • Address:
    Waltham, Massachusetts 02451, US
  • Name:
    FORD, David D.
  • Address:
    Waltham, Massachusetts 02451, US
  • Name:
    PARSONS, Andrew T.
  • Address:
    Thousand Oaks, CA 91320-1799, US
  • Name:
    ST-PIERRE, Gabrielle
  • Address:
    Thousand Oaks, CA 91320-1799, US
  • Name:
    TELMESANI, Reem
  • Address:
    Waltham, Massachusetts 02451, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    202063088848 P
  • Date:
    7.10.2020
  • Country:
    US
  • Number:
    202163162278 P
  • Date:
    17.3.2021
  • Country:
    US

Classification

  • Categories:
    C07D 471/04

Upload documents